SILVESTRI, MARCO
SILVESTRI, MARCO
Dipartimento di Medicina Molecolare e Traslazionale
A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer
2020-01-01 Reduzzi, C.; Vismara, M.; Silvestri, M.; Celio, L.; Niger, M.; Peverelli, G.; De Braud, F.; Daidone, M. G.; Cappelletti, V.
Analysis of single circulating tumor cells in renal cell carcinoma reveals phenotypic heterogeneity and genomic alterations related to progression
2020-01-01 Cappelletti, V.; Verzoni, E.; Ratta, R.; Vismara, M.; Silvestri, M.; Montone, R.; Miodini, P.; Reduzzi, C.; Claps, M.; Sepe, P.; Daidone, M. G.; Procopio, G.
Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy
2021-01-01 Ortolan, E; Appierto, V; Silvestri, M; Miceli, R; Veneroni, S; Folli, S; Pruneri, G; Vingiani, A; Belfiore, A; Cappelletti, V; Vismara, M; Dell'Angelo, F; De Cecco, L; Bianchi, G V; de Braud, F G; Daidone, M G; Di Cosimo, S
Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma
2023-01-01 Silvestri, Marco; Nghia Vu, Trung; Nichetti, Federico; Niger, Monica; Di Cosimo, Serena; De Braud, Filippo; Pruneri, Giancarlo; Pawitan, Yudi; Calza, Stefano; Cappelletti, Vera
Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer
2022-01-01 Silvestri, Marco; Dugo, Matteo; Vismara, Marta; De Cecco, Loris; Lanzoni, Davide; Vingiani, Andrea; Folli, Secondo; De Santis, Maria Carmen; de Braud, Filippo; Pruneri, Giancarlo; Di Cosimo, Serena; Cappelletti, Vera
CREDO: Highly confident disease-relevant A-to-I RNA-editing discovery in breast cancer
2019-01-01 Hwang, Woochang; Calza, Stefano; Silvestri, Marco; Pawitan, Yudi; Lee, Youngjo
Detection of genomically aberrant cells within circulating tumor microemboli (CTMs) isolated from early-stage breast cancer patients
2021-01-01 Silvestri, M.; Reduzzi, C.; Feliciello, G.; Vismara, M.; Schamberger, T.; Kostler, C.; Motta, R.; Calza, S.; Ferraris, C.; Vingiani, A.; Pruneri, G.; Daidone, M. G.; Klein, C. A.; Polzer, B.; Cappelletti, V.
Early modulation of circulating microRNAs levels in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy
2020-01-01 Di Cosimo, S.; Appierto, V.; Pizzamiglio, S.; Silvestri, M.; Baselga, J.; Piccart, M.; Huober, J.; Izquierdo, M.; de la Pena, L.; Hilbers, F. S.; de Azambuja, E.; Untch, M.; Pusztai, L.; Pritchard, K.; Nuciforo, P.; Vincent-salomon, A.; Symmans, F.; Apolone, G.; de Braud, F. G.; Iorio, M. V.; Verderio, P.; Daidone, M. G.
Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNA
2022-01-01 La Rocca, E; De Santis, M C; Silvestri, M; Ortolan, E; Valenti, M; Folli, S; de Braud, F G; Bianchi, G V; Scaperrotta, G P; Apolone, G; Daidone, M G; Cappelletti, V; Pruneri, G; Di Cosimo, S
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients
2020-01-01 Romani, Chiara; Zizioli, Valentina; Silvestri, Marco; Ardighieri, Laura; Bugatti, Mattia; Corsini, Michela; Todeschini, Paola; Marchini, Sergio; D'Incalci, Maurizio; Zanotti, Laura; Ravaggi, Antonella; Facchetti, Fabio; Gambino, Angela; Odicino, Franco; Sartori, Enrico; Santin, Alessandro Davide; Mitola, Stefania; Bignotti, Eliana; Calza, Stefano
Metabolic Footprints and Molecular Subtypes in Breast Cancer
2017-01-01 Cappelletti, V.; Iorio, E.; Miodini, P.; Silvestri, M.; Dugo, M.; Daidone, M. G.
PIERCE: Pipeline to InfER Cancer Evolution through circulating tumor cells in cholangiocarcinoma patients
2023-02-01 Silvestri, Marco
Primary tumor somatic mutations in the blood of women with ductal carcinoma in situ of the breast
2020-01-01 Di Cosimo, S.; Appierto, V.; Silvestri, M.; Ortolan, E.; De Cecco, L.; Veneroni, S.; Pruneri, G.; Vingiani, A.; Belfiore, A.; Scaperrotta, G.; Folli, S.; Daidone, M. G.
Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk
2022-01-01 De Mattia, Elena; Silvestri, Marco; Polesel, Jerry; Ecca, Fabrizio; Mezzalira, Silvia; Scarabel, Lucia; Zhou, Yitian; Roncato, Rossana; Lauschke, Volker M; Calza, Stefano; Spina, Michele; Puglisi, Fabio; Toffoli, Giuseppe; Cecchin, Erika
Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma
2022-01-01 Vismara, Marta; Reduzzi, Carolina; Silvestri, Marco; Murianni, Fabio; Lo Russo, Giuseppe; Fortunato, Orazio; Motta, Rosita; Lanzoni, Davide; Giovinazzo, Francesca; Miodini, Patrizia; Pasquali, Sandro; Suatoni, Paola; Pastorino, Ugo; Roz, Luca; Sozzi, Gabriella; Cappelletti, Vera; Bertolini, Giulia
Targeted-gene sequencing to catch triple negative breast cancer heterogeneity before and after neoadjuvant chemotherapy
2019-01-01 Di Cosimo, S.; Appierto, V.; Silvestri, M.; Pruneri, G.; Vingiani, A.; Perrone, F.; Busico, A.; Folli, S.; Scaperrotta, G.; de Braud, F. G.; Bianchi, G. V.; Cavalieri, S.; Daidone, M. G.; Dugo, M.
The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity
2023-01-01 De Mattia, E.; Polesel, J.; Silvestri, M.; Roncato, R.; Scarabel, L.; Calza, S.; Spina, M.; Puglisi, F.; Toffoli, G.; Cecchin, E.
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features
2021-01-01 Romani, C.; Capoferri, D.; Grillo, E.; Silvestri, M.; Corsini, M.; Zanotti, L.; Todeschini, P.; Ravaggi, A.; Bignotti, E.; Odicino, F.; Sartori, E.; Calza, S.; Mitola, S.
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells
2020-01-01 Reduzzi, C.; Vismara, M.; Gerratana, L.; Silvestri, M.; De Braud, F.; Raspagliesi, F.; Verzoni, E.; Di Cosimo, S.; Locati, L. D.; Cristofanilli, M.; Daidone, M. G.; Cappelletti, V.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer | 1-gen-2020 | Reduzzi, C.; Vismara, M.; Silvestri, M.; Celio, L.; Niger, M.; Peverelli, G.; De Braud, F.; Daidone, M. G.; Cappelletti, V. | |
| Analysis of single circulating tumor cells in renal cell carcinoma reveals phenotypic heterogeneity and genomic alterations related to progression | 1-gen-2020 | Cappelletti, V.; Verzoni, E.; Ratta, R.; Vismara, M.; Silvestri, M.; Montone, R.; Miodini, P.; Reduzzi, C.; Claps, M.; Sepe, P.; Daidone, M. G.; Procopio, G. | |
| Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy | 1-gen-2021 | Ortolan, E; Appierto, V; Silvestri, M; Miceli, R; Veneroni, S; Folli, S; Pruneri, G; Vingiani, A; Belfiore, A; Cappelletti, V; Vismara, M; Dell'Angelo, F; De Cecco, L; Bianchi, G V; de Braud, F G; Daidone, M G; Di Cosimo, S | |
| Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma | 1-gen-2023 | Silvestri, Marco; Nghia Vu, Trung; Nichetti, Federico; Niger, Monica; Di Cosimo, Serena; De Braud, Filippo; Pruneri, Giancarlo; Pawitan, Yudi; Calza, Stefano; Cappelletti, Vera | |
| Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer | 1-gen-2022 | Silvestri, Marco; Dugo, Matteo; Vismara, Marta; De Cecco, Loris; Lanzoni, Davide; Vingiani, Andrea; Folli, Secondo; De Santis, Maria Carmen; de Braud, Filippo; Pruneri, Giancarlo; Di Cosimo, Serena; Cappelletti, Vera | |
| CREDO: Highly confident disease-relevant A-to-I RNA-editing discovery in breast cancer | 1-gen-2019 | Hwang, Woochang; Calza, Stefano; Silvestri, Marco; Pawitan, Yudi; Lee, Youngjo | |
| Detection of genomically aberrant cells within circulating tumor microemboli (CTMs) isolated from early-stage breast cancer patients | 1-gen-2021 | Silvestri, M.; Reduzzi, C.; Feliciello, G.; Vismara, M.; Schamberger, T.; Kostler, C.; Motta, R.; Calza, S.; Ferraris, C.; Vingiani, A.; Pruneri, G.; Daidone, M. G.; Klein, C. A.; Polzer, B.; Cappelletti, V. | |
| Early modulation of circulating microRNAs levels in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy | 1-gen-2020 | Di Cosimo, S.; Appierto, V.; Pizzamiglio, S.; Silvestri, M.; Baselga, J.; Piccart, M.; Huober, J.; Izquierdo, M.; de la Pena, L.; Hilbers, F. S.; de Azambuja, E.; Untch, M.; Pusztai, L.; Pritchard, K.; Nuciforo, P.; Vincent-salomon, A.; Symmans, F.; Apolone, G.; de Braud, F. G.; Iorio, M. V.; Verderio, P.; Daidone, M. G. | |
| Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNA | 1-gen-2022 | La Rocca, E; De Santis, M C; Silvestri, M; Ortolan, E; Valenti, M; Folli, S; de Braud, F G; Bianchi, G V; Scaperrotta, G P; Apolone, G; Daidone, M G; Cappelletti, V; Pruneri, G; Di Cosimo, S | |
| Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients | 1-gen-2020 | Romani, Chiara; Zizioli, Valentina; Silvestri, Marco; Ardighieri, Laura; Bugatti, Mattia; Corsini, Michela; Todeschini, Paola; Marchini, Sergio; D'Incalci, Maurizio; Zanotti, Laura; Ravaggi, Antonella; Facchetti, Fabio; Gambino, Angela; Odicino, Franco; Sartori, Enrico; Santin, Alessandro Davide; Mitola, Stefania; Bignotti, Eliana; Calza, Stefano | |
| Metabolic Footprints and Molecular Subtypes in Breast Cancer | 1-gen-2017 | Cappelletti, V.; Iorio, E.; Miodini, P.; Silvestri, M.; Dugo, M.; Daidone, M. G. | |
| PIERCE: Pipeline to InfER Cancer Evolution through circulating tumor cells in cholangiocarcinoma patients | 1-feb-2023 | Silvestri, Marco | |
| Primary tumor somatic mutations in the blood of women with ductal carcinoma in situ of the breast | 1-gen-2020 | Di Cosimo, S.; Appierto, V.; Silvestri, M.; Ortolan, E.; De Cecco, L.; Veneroni, S.; Pruneri, G.; Vingiani, A.; Belfiore, A.; Scaperrotta, G.; Folli, S.; Daidone, M. G. | |
| Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk | 1-gen-2022 | De Mattia, Elena; Silvestri, Marco; Polesel, Jerry; Ecca, Fabrizio; Mezzalira, Silvia; Scarabel, Lucia; Zhou, Yitian; Roncato, Rossana; Lauschke, Volker M; Calza, Stefano; Spina, Michele; Puglisi, Fabio; Toffoli, Giuseppe; Cecchin, Erika | |
| Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma | 1-gen-2022 | Vismara, Marta; Reduzzi, Carolina; Silvestri, Marco; Murianni, Fabio; Lo Russo, Giuseppe; Fortunato, Orazio; Motta, Rosita; Lanzoni, Davide; Giovinazzo, Francesca; Miodini, Patrizia; Pasquali, Sandro; Suatoni, Paola; Pastorino, Ugo; Roz, Luca; Sozzi, Gabriella; Cappelletti, Vera; Bertolini, Giulia | |
| Targeted-gene sequencing to catch triple negative breast cancer heterogeneity before and after neoadjuvant chemotherapy | 1-gen-2019 | Di Cosimo, S.; Appierto, V.; Silvestri, M.; Pruneri, G.; Vingiani, A.; Perrone, F.; Busico, A.; Folli, S.; Scaperrotta, G.; de Braud, F. G.; Bianchi, G. V.; Cavalieri, S.; Daidone, M. G.; Dugo, M. | |
| The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity | 1-gen-2023 | De Mattia, E.; Polesel, J.; Silvestri, M.; Roncato, R.; Scarabel, L.; Calza, S.; Spina, M.; Puglisi, F.; Toffoli, G.; Cecchin, E. | |
| The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features | 1-gen-2021 | Romani, C.; Capoferri, D.; Grillo, E.; Silvestri, M.; Corsini, M.; Zanotti, L.; Todeschini, P.; Ravaggi, A.; Bignotti, E.; Odicino, F.; Sartori, E.; Calza, S.; Mitola, S. | |
| The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells | 1-gen-2020 | Reduzzi, C.; Vismara, M.; Gerratana, L.; Silvestri, M.; De Braud, F.; Raspagliesi, F.; Verzoni, E.; Di Cosimo, S.; Locati, L. D.; Cristofanilli, M.; Daidone, M. G.; Cappelletti, V. |